Charles River Laboratories International Inc’s recent filing unveils that its Officer Joseph LaPlume acquired Company’s shares for reported $72160.0 on May 13 ’25. In the deal valued at $144.32 per share,500 shares were bought.
Then, FOSTER JAMES C bought 6,075 shares, generating $1,002,436 in total proceeds. Upon buying the shares at $165.01, the Chairman, President and CEO now owns 183,639 shares.
Before that, Girshick Birgit bought 1,514 shares. Charles River Laboratories International Inc shares valued at $249,250 were divested by the Corporate Executive VP & COO at a price of $164.63 per share. As a result of the transaction, Girshick Birgit now holds 55,058 shares, worth roughly $7.93 million.
Evercore ISI upgraded its Charles River Laboratories International Inc [CRL] rating to an Outperform from a an In-line in a research note published recently. A number of analysts have revised their coverage, including Goldman’s analysts, who decreased its forecast for the stock in late March from “a Buy” to “a Neutral”. Citigroup also remained covering CRL and has increased its forecast on March 04, 2025 with a “Neutral” recommendation from previously “Sell” rating. Redburn Atlantic revised its rating on March 03, 2025. It rated CRL as “a Neutral” which previously was an “a Sell”.
Price Performance Review of CRL
On Tuesday, Charles River Laboratories International Inc [NYSE:CRL] saw its stock jump 0.66% to $144.02. Over the last five days, the stock has gained 24.79%. Charles River Laboratories International Inc shares have fallen nearly -21.98% since the year began. Nevertheless, the stocks have fallen -37.41% over the past one year. While a 52-week high of $254.15 was reached on 01/07/25, a 52-week low of $91.86 was recorded on 04/11/25. SMA at 50 days reached $140.07, while 200 days put it at $177.60.
Levels Of Support And Resistance For CRL Stock
The 24-hour chart illustrates a support level at 141.59, which if violated will result in even more drops to 139.17. On the upside, there is a resistance level at 146.04. A further resistance level may holdings at 148.07. The Relative Strength Index (RSI) on the 14-day chart is 62.74, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 16.55, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 9.16%. Stochastics %K at 88.60% indicates the stock is a selling.
